Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Tidsskr Nor Laegeforen ; 136(17): 1425, 2016 Sep.
Article in Norwegian | MEDLINE | ID: mdl-27686191
2.
Tidsskr Nor Laegeforen ; 134(1): 8-9, 2014 Jan 14.
Article in Norwegian | MEDLINE | ID: mdl-24429745

Subject(s)
Melanoma , Skin Neoplasms , Humans
3.
J Clin Endocrinol Metab ; 96(9): 2750-5, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21715533

ABSTRACT

CONTEXT: Repeated neck explorations can be a difficult task in patients with recurrent metastatic cervical lymph nodes from papillary thyroid carcinoma (PTC). OBJECTIVE: The aim of this retrospective study has been to assess the efficacy of ultrasound (US)-guided percutaneous ethanol injection (PEI) as treatment of metastatic cervical lymph nodes from PTC. MATERIALS AND METHODS: Sixty-nine patients who previously had undergone thyroidectomy for PTC were selected for inclusion. However, three patients were later excluded due to lack of follow-up. Lymph node status was determined by US-guided fine-needle aspiration biopsy and/or by raised levels of thyroglobulin in washouts from the cytological needle. Guided by US, 0.1-1.0 ml of 99.5% ethanol was injected into the metastatic lymph nodes. RESULTS: Three patients (eight metastatic lymph nodes in total) were reassigned to surgery due to progression (multiple new metastases), leaving 63 patients and 109 neck lymph nodes to be included. Mean observation time was 38.4 months (range, 3-72). A total of 101 of the 109 (93%) metastatic lymph nodes responded to PEI treatment, 92 (84%) completely and nine incompletely. Two did not respond, and four progressed. Two lymph nodes previously considered successfully treated showed evidence of malignancy during follow-up. No significant side effects were reported. CONCLUSION: US-guided PEI treatment of metastatic lymph nodes seems to be an excellent alternative to surgery in patients with a limited number of neck metastases from PTC. This procedure should replace "berry picking" surgery.


Subject(s)
Carcinoma, Papillary/drug therapy , Ethanol/administration & dosage , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis/pathology , Thyroid Neoplasms/drug therapy , Administration, Cutaneous , Adult , Aged , Biopsy, Fine-Needle , Carcinoma , Carcinoma, Papillary/diagnostic imaging , Carcinoma, Papillary/pathology , Ethanol/therapeutic use , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis/diagnostic imaging , Male , Middle Aged , Thyroid Cancer, Papillary , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/pathology , Treatment Outcome , Ultrasonography
4.
Tidsskr Nor Laegeforen ; 124(18): 2359-61, 2004 Sep 23.
Article in Norwegian | MEDLINE | ID: mdl-15467800

ABSTRACT

BACKGROUND: Application of fine needle cytology (FNC) is important in the preoperative assessment of thyroid lesions. The method is rapid, minimally invasive and cost effective. The aim of this study was to evaluate the role of fine needle cytology at The Norwegian Radium Hospital in the management of thyroid nodules. MATERIAL AND METHODS: Data on FNC and comparable histology results were retrieved from the pathology database during the 5-year-period 1998 through 2003. 1770 FNC samples and corresponding histology results from 443 lesions were compared. Reviews of cytological slides were done in 39 discrepant cases and quality assessment parameters calculated. RESULTS: High complete sensitivity (77.5%) and specificity (90.1%) were found. The false positive rate was 1.2% and the false negative rate 23.7%. Inadequate FNCs were particularly seen in submitted specimens. A review of the discrepant cases showed that the main cause of false negative samples was sampling error. Micropapillary carcinoma was the predominant tumour type with false negative FNC. Eleven malignancies were diagnosed in repeat FNC specimens. INTERPRETATION: FNC is a highly reliable test to assess whether a thyroid nodule is benign or malignant. Diagnostic pitfalls are mainly due to inability to procure the diagnostic material.


Subject(s)
Biopsy, Fine-Needle/standards , Carcinoma/pathology , Thyroid Gland/pathology , Thyroid Neoplasms/pathology , Thyroid Nodule/pathology , Biopsy, Fine-Needle/economics , Biopsy, Fine-Needle/statistics & numerical data , Cost-Benefit Analysis , False Negative Reactions , False Positive Reactions , Humans , Sensitivity and Specificity , Specimen Handling/standards
5.
Eur Urol ; 42(3): 221-8; discussion 228, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12234506

ABSTRACT

PURPOSE: There are few reports on the use of fine needle cytology (FNC) for the detection of retroperitoneal lymph node metastases from malignant germ cell tumours (MGCT). In order to determine efficiency of the procedure and its impact on therapeutic approaches, this study reviews experience with ultrasound-guided transabdominal FNC in patients with MGCT. PATIENTS AND METHODS: Twenty-four patients with known malignant germ cell tumour and four patients without previous histology, presented with retroperitoneal masses. They underwent ultrasound-guided fine needle cytology (aspirations were done twice in two patients). Clinical data were retrieved from the medical records and all cytological specimens were reviewed. In metastatic cases, the cytologic findings were correlated with the histology of the primary tumour. RESULTS: Twenty-one of 30 specimens (70%) were diagnosed as malignant, 6 (20%) were benign, and 3 (10%) were unsatisfactory for the cytologic diagnosis. Five of the 21 malignant lesions were < or =10mm. FNC yielded the correct diagnosis in all four cases of extragonadal malignant germ cell tumours. In four other patients, FNC solved significant staging problems at the diagnosis. In 7 of 11 patients with the suspicion of retroperitoneal recurrence and normal serum tumour markers during follow-up, FNC confirmed the malignant morphology of the lesions. CONCLUSIONS: In experienced hands, ultrasound-guided FNC can be a valuable method for the morphological diagnosis of retroperitoneal manifestations from MGCT. FNC should be added in follow-up and staging procedures (radiological imaging and serum tumour markers) in selected patients in whom the histological verification of such lesions is critical for the patient's management.


Subject(s)
Biopsy, Needle/methods , Germinoma/pathology , Neoplasm Recurrence, Local/pathology , Retroperitoneal Neoplasms/pathology , Adolescent , Adult , Biomarkers, Tumor/blood , Combined Modality Therapy , Female , Humans , Lymphatic Metastasis/diagnostic imaging , Lymphatic Metastasis/pathology , Male , Middle Aged , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/therapy , Neoplasm Staging , Retroperitoneal Neoplasms/diagnostic imaging , Retroperitoneal Neoplasms/therapy , Ultrasonography/methods
6.
Eur Urol ; 42(3): 229-38; discussion 237-8, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12234507

ABSTRACT

OBJECTIVE: To evaluate gonadal function and fertility in patients with bilateral testicular cancer (TC). METHODS: In 1999, 63 patients with bilateral invasive TC or carcinoma in situ (CIS) in the contralateral testis completed a mailed questionnaire evaluating their fatherhood (Cases). Their gonadal function had also been assessed after the first orchiectomy for TC before further treatment. The results were compared with those from 174 patients with unilateral TC (Controls). RESULTS: In Cases the post-orchiectomy serum levels of FSH and LH were above those of the Controls (p<0.001). Serum testosterone was similar, whereas sperm concentrations were lower in Cases (p<0.001). In Cases with metachronous invasive TC the level of serum FSH was associated with the interval between the two diagnoses. After the first orchiectomy, 10 of 25 Cases (40%) initiated a pregnancy, in 4 Cases by assisted fertilization. In the Control group 74% of the patients who attempted fatherhood succeeded (p=0.002). CONCLUSIONS: After unilateral orchiectomy for TC elevated serum FSH and/or oligospermia represent a high-risk factor of metachronous bilateral TC or synchronous CIS. At least one-third of these patients attempting fatherhood are successful after the first orchiectomy. Assisted fertilization is often necessary and the overall paternity rate is below that of patients with unilateral TC.


Subject(s)
Fertility/physiology , Infertility, Male/etiology , Neoplasms, Germ Cell and Embryonal/physiopathology , Orchiectomy/adverse effects , Testicular Neoplasms/physiopathology , Testis/physiopathology , Adolescent , Adult , Carcinoma in Situ/complications , Carcinoma in Situ/physiopathology , Carcinoma in Situ/surgery , Combined Modality Therapy , Follicle Stimulating Hormone/blood , Gonadal Steroid Hormones/blood , Humans , Luteinizing Hormone/blood , Male , Middle Aged , Neoplasms, Germ Cell and Embryonal/complications , Neoplasms, Germ Cell and Embryonal/surgery , Sperm Count , Testicular Neoplasms/complications , Testicular Neoplasms/surgery , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...